May 20 (Reuters) - European Medicines Agency:

* EMA: EMA STARTED EVALUATING THE USE OF A BOOSTER DOSE OF NOVAVAX'S COVID-19 VACCINE, NUVAXOVID, IN ADULTS: 20/05/2022 Further company coverage: